Home About us Contact
|
Home About us Contact | ||
|
|
||
Sulforhodamine B (sulforhodamine + b)
Selected AbstractsMaterials for a Reliable Solid-State Dye Laser at the Red Spectral EdgeADVANCED FUNCTIONAL MATERIALS, Issue 16 2009Inmaculada Garcia-Moreno Abstract In the search to extend the tuning range of solid-state dye lasers (SSDLs) to the red-edge spectral region, new photosensitive materials have been designed and synthesized based on six commercial dyes (sulforhodamine B, perylene red, rhodamine 640, LDS698, LDS722, and LDS730) incorporated into different linear, crosslinked, fluorinated, and sililated polymeric matrices. Under transversal pumping at 532,nm, these materials exhibit highly efficient, stable, as well as wavelength-tunable laser action from the visible-to-NIR spectral region (575,750,nm). The lasing performance of the materials doped with perylene and xanthene dyes is, to the best of our knowledge, the highest achieved to date for these chromophores when incorporated into organic, inorganic, or hybrid matrices. Regarding the LDS derivatives, this is the first time that laser action from these dyes in solid-state media is reported. These particular characteristics have impelled the building of the first prototype SSDL that is compact, versatile, and easy to handle. [source] TC -tuned biocompatible suspension of La0.73Sr0.27MnO3 for magnetic hyperthermiaJOURNAL OF BIOMEDICAL MATERIALS RESEARCH, Issue 2 2008N. K. Prasad Abstract La1,xSrxMnO3, a ferromagnet with high magnetization and Curie temperature TC below 70°C, enables its use for magnetic hyperthermia treatment of cancer with a possibility of in vivo temperature control. We found that La0.73Sr0.27MnO3 particles of size range 20,100 nm showed saturation magnetization around 38 emu/g at 20 kOe and a TC value of 45°C. Aqueous suspension of these nanoparticles was prepared using a polymer, acrypol 934, and the biocompatibility of the suspension was examined using HeLa cells. A good heating ability of the magnetic suspension was obtained in the presence of AC magnetic field, and it was found to increase with the amplitude of field. The suspension having concentration of 0.66 mg/mL (e.g., 0.66 mg of nanoparticles with acropyl per milliliter of culture media) was observed to be biocompatible even after 96 h of treatment, as estimated by sulforhodamine B and trypan blue dye exclusion assays. Further, the treatment with the aforementioned concentration did not alter the microtubule cytoskeleton or the nucleus of the cells. However, the bare particles (concentration of 0.66 mg of nanoparticles per milliliter of culture media, but without acropyl) decreased the viability of cell significantly. Our in vitro studies suggest that the suspension (concentration of 0.66 mg/mL) may further be analyzed for in vivo studies. © 2007 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2008 [source] Evaluation of fluorescent probe surface intensities as an indicator of transdermal permeant distributions using wide-area two-photon fluorescence microscopyJOURNAL OF PHARMACEUTICAL SCIENCES, Issue 12 2003Betty Yu Abstract The application of high-speed two-photon fluorescence microscopy (HTPM) to examine transdermal transport processes has enabled the noninvasive visualization of permeant spatial distributions over a larger, more clinically relevant wide area of the skin. Earlier studies demonstrated that the transdermal fluorescent probe distribution over a 2,×,2 mm skin area was well represented by a significantly reduced sampling of the 400 microscale skin sites (100,×,100 ,m) constituting the wide area. In the present study, the 400 microscale skin sites are considered individually, and the site-to-site variability in permeant distributions is used as a model to reflect the range in experimentally measured skin permeabilities resulting from the inherent stratum corneum structural heterogeneity. The correlation established between the permeant surface intensity and the corresponding permeant intensity gradient at each skin site provides an indication of the potential for screening transdermal permeant distributions solely based on the evaluation of microscale permeant surface intensities. The strong linear correlation between the intensity gradient and the surface intensity for the hydrophilic model permeant, sulforhodamine B, demonstrated that surface intensities provide a robust indicator of the corresponding transdermal probe distributions at the microscale. For the hydrophobic model permeant, rhodamine B hexyl ester, however, weak correlations were observed between these two parameters. This result suggests that the stratum corneum microscale surface intensity does not validly capture the corresponding intensity gradients for the entire range of skin permeabilities typically encountered as a result of the inherent stratum corneum heterogeneity. © 2003 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 92:2354,2365, 2003 [source] Encapsulation of naturally occurring flavonoids into liposomes: physicochemical properties and biological activity against human cancer cell linesJOURNAL OF PHARMACY AND PHARMACOLOGY: AN INTERNATI ONAL JOURNAL OF PHARMACEUTICAL SCIENCE, Issue 10 2004M. Goniotaki Liposomes consisting of egg phosphatidylcholine were prepared by a thin-film hydration method followed by sonication and were used to investigate the percentage encapsulation of four flavonoids (quercetin, rutin, isoscutellarein and isoscutellarein diglycoside). The lipid recovery and the flavonoid-to-lipid molar ratio were measured using high-performance thin-layer chromatography/flame ionization detection and UV-vis spectroscopy. Differential scanning calorimetry was used to study the effect of the flavonoids on the phase transition temperature and on the enthalpy of the main phase transition of dipalmitoylphosphatidylcholine bilayers, and their ability to influence the membrane fluidity. The final liposomal formulation incorporating flavonoids, as well as free flavonoids, were tested for their activity against human cancer cell lines using the sulforhodamine B assay. The results showed that the encapsulation efficiency varied from 95% (0.21 flavonoid-to-lipid molar ratio) to 37.5% (0.09 flavonoid-to-lipid molar ratio) for isoscutellarein and its glycoside, respectively. The differential scanning calorimetry data showed close thermal and dynamic effects depending on the structure of the flavonoids, and suggest that there is a relationship between flavonoid molecular structure and the interaction with model membranes. Liposomal isoscutellarein showed improved growth inhibiting activity against all cell lines tested in comparison with that of its free form, which was inactive (>100 ,M). [source] Synergistic interaction between trifluorothymidine and docetaxel is sequence dependentCANCER SCIENCE, Issue 11 2008I.V. Bijnsdorp Docetaxel is a microtubule inhibitor that has actions in the S and G2,M phase of the cell cycle. The pyrimidine trifluorothymidine (TFT) induces DNA damage and an arrest in the G2,M phase. TFT, as part of TAS-102, has been clinically evaluated as an oral chemotherapeutic agent in colon and gastric cancer. The aim of the present study was to determine the optimal administration sequence of TFT and docetaxel and to investigate the underlying mechanism of cytotoxicity. Drug interactions were examined by sulforhodamine B assays and subsequent combination index analyses, and for long-term effects the clonogenic assay was used. A preincubation with docetaxel was synergistic in sulforhodamine B (combination index 0.6,0.8) and clonogenic assays, and was accompanied by a time-dependent cell death induction (17,36%), the occurrence of polynucleation (22%), and mitotic spindle inhibition as determined by flow cytometry and immunostaining. Interestingly, administration of TFT followed by the combination displayed strong antagonistic activity, and was accompanied by less polynucleation and cell death induction than the synergistic combinations. Western blotting showed that the G2,M-phase arrest (25,50%) was accompanied by phosphorylation of Chk2 and dephosphorylation of cdc25c in the synergistic combinations. Together, this indicates that synergistic activity requires docetaxel to initiate mitotic failure prior to the activation of TFT damage signaling, whereas antagonism is a result of TFT cell cycle-arrested cells being less susceptible to docetaxel. Caspase 3 activation was low after docetaxel, suggestive of caspase-independent mechanisms of cell death. Taken together, our models indicate that combination treatment with docetaxel and TFT displays strong synergy when docetaxel is given first, thus providing clues for possible clinical studies. (Cancer Sci 2008; 99: 2302,2308) [source] | |||||||||||||